These results indicate that Bmi-1 contributes the IR-induced EMT process and migration of breast cancer cells via PI3K/Akt pathway; and suggest that Bmi-1 could be a potential target for suppression of metastatic potential of breast cancer cells with or without IR. The gene discussed is BMI1; the disease is breast carcinoma.